查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2100344

視力保健市場－2026-2032年全球市場預測

Vision Care Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，視力保健市場將成長至 1,625.1 億美元，複合年成長率為 8.50%。

主要市場統計數據
基準年 2025 917.8億美元
預計年份：2026年 985.8億美元
預測年份 2032 1625.1億美元
複合年成長率 (%) 8.50%

視力保健執行摘要：眼睛健康、醫療服務和數位轉型

視力保健正從以產品為中心的領域發展成為一個更廣泛的眼部健康生態系統，涵蓋處方眼鏡、隱形眼鏡、眼科檢查、屈光矯正、乾眼症管理、近視進展控制、數位眼疲勞緩解以及便捷的初級眼科護理。人口老化、螢幕使用時間增加、人們對可預防性視力障礙的認知不斷提高以及驗光和眼科服務的普及，共同推動了這一需求的成長。根據世界衛生組織（世衛組織）統計，至少有22億人因近視或遠視而患有視力障礙，其中至少10億人估計是可以預防的，或尚未接受適當的治療。這凸顯了及時眼科護理對公眾健康的重要性。大量證據表明，未矯正的屈光不正、白內障、青光眼、糖尿病視網膜病變和老齡化黃斑部病變與生產力下降、學習能力受損、可預防性殘疾以及護理負擔加重密切相關。因此，視力保健正日益被視為一項必不可少的醫療保健服務，而不僅僅是可有可無的消費品。此外，混合辦公模式、電子設備使用增加、兒童戶外活動減少以及影響眼部健康的代謝性疾病盛行率上升等生活方式的改變也對該領域產生了影響。這些因素促使相關人員將臨床品質、可負擔性、早期檢測、病患教育和全通路服務結合。對於行業領導者而言，最大的機會在於改善精準眼科檢查、循證治療方案、耐用正畸產品和數位化驅動的持續護理的可及性，同時應對監管、報銷機制不一致、人才短缺以及消費者對便捷性和個性化服務的期望等挑戰。

眼科醫療服務體系的變革性改革。

在眼科領域，預防性眼部健康管理、互聯診斷和以患者為中心的服務模式正在推動變革。消費者越來越追求便捷，例如線上預約、數位處方箋管理、眼鏡和隱形眼鏡宅配，以及實體診所和線上管道之間的無縫銜接。同時，臨床標準仍然至關重要，因為準確的屈光檢查、眼科疾病篩檢、隱形眼鏡驗配和手術轉診都需要訓練有素的專業人員和檢驗的設備。近視管理已成為一項重要的策略重點，尤其是在許多都市區兒童近視率上升、戶外活動時間增加以及專業光學設計、阿托品治療和系統監測等乾預措施已被證實有效的情況下。乾眼症和數位眼睛疲勞也在改變人們的需求，因為長時間使用電子螢幕會導致不適和視力下降，從而增加了對潤滑劑、人體工學指導和臨床評估的需求。另一個顯著的變化是將眼科護理與慢性病（特別是糖尿病和高血壓）的管理相結合。視網膜檢查有助於早期發現併發症。根據國際糖尿病聯盟 (IDF) 估計，全球數億成年人患有糖尿病，因此，建立系統性的糖尿病視網膜病變篩檢和轉診體系的需求日益成長。醫療設備、線上視力檢查、隱形眼鏡安全、資料隱私和廣告行為的監管力度不斷加強，使得合規性和臨床管治成為關鍵的差異化因素。隨著醫療保健機構和製造商應對包裝廢棄物、鏡片處理、鏡框材料、能源消耗和負責任的供應鏈等挑戰，永續性也變得越來越重要。

人工智慧對視力保健的累積影響

人工智慧 (AI) 透過提高篩檢效率、最佳化臨床工作流程、改善患者分診和最佳化營運決策，對整體視力保健領域產生了累積的影響。 AI 驅動的影像分析在糖尿病視網膜病變篩檢、識別青光眼風險指標、表徵老齡化黃斑部病變以及診斷其他眼部觀察尤其重要。檢驗的系統即使在專家資源有限的環境中也能支援早期轉診並減少瓶頸。在驗光和眼科實踐中，AI 可以輔助預約優先排序、創建診斷記錄、解讀視野檢查結果、最佳化鏡片推薦流程以及加強與患者的溝通。 AI 驅動的個人化服務也有助於提升使用者體驗，例如支援鏡框選擇、虛擬試戴、提醒系統、鼓勵隱形眼鏡定期更換的通知以及根據患者風險狀況量身定做的健康教育。然而，AI 的應用必須基於實證醫學、透明度、合規性和負責任的資料管治。臨床人工智慧需要具有代表性的資料集、持續檢驗、明確的課責、與現有系統的互通性，以及防止可能影響服務不足人口的偏見的措施。當人工智慧透過自動化重複性任務、擴大篩檢範圍和實現更一致的隨訪，來「補充」而非「取代」合格的眼科醫護人員時，才能發揮最大的作用。將人工智慧與人工監督、安全的醫療數據基礎設施和可衡量的臨床結果相結合的機構，更有能力在整個視力保健過程中提高服務的可及性和品質。

亞太地區、北美地區、拉丁美洲地區、歐洲地區以及中東和非洲地區的關鍵區域洞察

亞太地區人口基數龐大，都市化迅速，屈光不正盛行率高，且對可擴展的近視管理和白內障治療服務需求迫切，因此該地區的眼科保健至關重要。該地區多個國家報告稱，學齡兒童近視率居高不下，公共衛生計畫日益重視學校視力篩檢、推廣戶外活動、普及眼鏡零售商服務以及推廣數位化醫療。然而，大都會圈和農村地區在眼科保健服務取得方面仍然存在差距。在北美，由於先進的臨床基礎設施、消費者意識的提高以及數位化應用的普及，對處方眼鏡、隱形眼鏡、眼科診斷、屈光矯正手術、乾眼症治療以及慢性眼科疾病監測的需求已趨於成熟。然而，成本效益以及農村地區獲得專科醫生服務的可近性仍然是亟待解決的問題。在拉丁美洲，都市區眼鏡零售業的發展、與可預防性視力障礙相關的公共衛生需求以及不同收入水平和地區獲得專科醫生服務的差異，使得獲得價格合理的屈光檢查和白內障治療變得至關重要。在歐洲，完善的醫療保健體系、健全的醫療設備法規結構、人口老化以及對高品質眼科檢查、老花眼管理、白內障治療、青光眼後續觀察和視網膜疾病管理的需求，共同推動了眼科需求的成長。在中東，透過專科醫療保健、糖尿病相關眼科檢查、對高階眼科服務的投資以及部分市場醫療旅遊的拓展，眼科醫療服務正在取得進展，但資源匱乏和偏遠地區的居民在獲得醫療保健方面仍然存在差距。在非洲，未矯正屈光不正、白內障治療和可預防性失明方面仍存在大量未滿足的需求，這夥伴關係。

主要集團分析涵蓋東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約。

東協的眼科保健趨勢受到人口結構年輕化、都市區螢幕使用時間增加、兒童近視率上升以及眼鏡零售網路不斷擴張等因素的影響。在收入水平多元化的環境下，以學校為基礎的篩檢、價格合理的矯正鏡片以及數位化驅動的病人參與至關重要。海灣合作理事會（GCC）國家受到醫療保健領域大量投資、糖尿病高發、對高品質眼科服務的需求以及先進眼科診斷技術日益普及的影響，因此，整合視網膜篩檢和獲得專科護理尤為重要。歐盟強調醫療設備監管、病人安全、跨境標準、永續性和可近性，並結合公私醫療模式，支持眼鏡、隱形眼鏡、診斷和手術治療途徑中一致的品質要求。金磚國家（BRICS）市場人口眾多、收入水平差異顯著、製造業能力有限且未滿足的需求巨大，因此需要可擴展的、價格合理的、本地化的配銷通路、遠程眼科護理以及公私合營的篩檢模式來改善視力保健服務的可及性。七國集團（G7）國家普遍擁有先進的臨床基礎設施、老齡化人口、高發的老花眼和慢性眼科疾病，以及強大的數位醫療應對力，所有這些都為診斷創新、人工智慧輔助篩檢和個人化視力矯正提供了支持。北約成員國的醫療衛生體系與多個已開發國家和新興國家的醫療衛生體系存在重疊，在這些國家，國防、職業戰備、勞動力生產力和獲得視力矯正服務至關重要，尤其是在安全關鍵崗位上，精準的視覺能力和定期的眼部健康監測必不可少。

針對主要視力保健市場的特定國家洞察

美國擁有高度發展的視力保健體系，對眼科檢查、眼鏡、隱形眼鏡、屈光矯正手術和視網膜疾病監測的需求旺盛，但成本效益、保險覆蓋範圍以及農村地區的就醫便利性仍然是亟待解決的重要問題。在加拿大，人口老化、公眾健康意識的提高以及驗光和眼科服務保險覆蓋範圍的區域差異，使得獲得醫療保健和持續護理成為一項關鍵優先事項。在墨西哥，儘管都市區對光學產品和眼科保健服務的需求不斷成長，但人們仍然需要獲得價格合理的屈光手術和白內障治療。在巴西，都市區醫療保健系統能夠提供視力矯正、糖尿病眼科疾病篩檢和白內障治療，但地理和收入差距仍然是挑戰。在英國，驗光服務體系完善，眼科檢查流程也已建立，但與老齡化相關的眼科疾病以及眼科預約等待時間過長等問題日益凸顯。德國的特點是臨床標準高、對高階鏡片和眼科技術的需求旺盛，並且對老花眼、白內障和視網膜疾病的治療非常重視。在法國，除了醫療保健的標準化和對成熟光學產品的需求外，人們還持續關注保險報銷、醫療品質以及及時轉診專科醫生。在俄羅斯，廣大的地區對屈光矯正和眼科服務的需求普遍存在，但主要城市和偏遠地區的醫療資源取得卻不盡相同。義大利和西班牙都面臨著人口老化、對老花眼和白內障解決方案的需求以及對視網膜疾病、乾眼症和數位眼疲勞日益成長的關注。在中國，近視是一個重大挑戰，尤其是在兒童和學生群體中，人們對眼科診斷、近視進展控制、白內障治療和基於數位健康的篩檢的需求日益成長。在印度，屈光矯正、白內障治療和糖尿病視網膜病變篩檢方面存在大量未滿足的需求，而可負擔性、社區推廣、遠距眼科護理和本地服務能力是取得進展的關鍵。日本是世界上老化程度最高的國家之一，其特徵是近視、白內障、青光眼和視網膜疾病的盛行率高，以及對高階光學解決方案的高需求。澳洲擁有許多優勢，例如驗光服務普及率高，公眾健康意識強，但偏遠地區和原住民社區仍需要有針對性的支持和符合當地文化的服務。韓國的特點是電子設備使用率高、近視盛行率高、擁有先進的眼科醫療保健體系，以及消費者對高階眼鏡、隱形眼鏡和屈光護理的需求。

為視力保健行業領導者提供的實用建議

行業領導者應優先考慮經臨床驗證、易於獲取且以患者為中心的視力保健模式。首先，透過整合全面的眼科檢查、學校視力篩檢、職場眼健康計畫以及與慢性疾病相關的視網膜評估，擴大早期檢測範圍。其次，透過實證方案、家長教育、定期追蹤以及符合當地法規的適當光學或藥物治療介入措施，提升近視管理能力。第三，透過分級產品線、耐用且價格低廉的眼鏡、全面的資金籌措方案以及與服務不足地區的公共衛生組織合作，實現可負擔性。第四，投資全通路服務，整合實體診所、驗光師、遠距眼科、安全醫療記錄和數位提醒，同時確保臨床準確性。第五，只有在明確建立檢驗、隱私保護、減少偏見和專家監督機制的情況下，才能引入人工智慧和自動化技術。第六，我們將透過支援驗光師和技術人員的培訓、協調轉診患者以及推行工作共享模式來解決人員短缺問題，同時維持服務品質。第七，我們將透過透明的收費方式、隱形眼鏡安全教育、術後追蹤以及對治療限制的清晰解釋來建立信任。最後，隨著環保意識在採購、監管和消費者選擇中日益重要，我們將把永續性融入產品設計、包裝、物流和回收活動中。

基於證據的視力保健情報調查方法

一套完善的視力保健調查方法需要結合一手研究和二手研究，以確保研究結果的準確性、相關性和可操作性。一手研究包括對驗光師、眼科醫生、眼鏡零售商、鏡片專家、診斷服務提供者、公共衛生專業人員、採購負責人和患者護理服務提供者進行結構化訪談。二手研究則從同行評審的眼科和驗光文獻、世界衛生組織 (WHO) 資料、公共衛生資料庫、監管出版刊物、臨床指南、人口統計資料集、保險報銷參考資料、醫療設備標準和國家眼健康計劃中收集資訊。研究從多個角度檢視證據，包括臨床負擔、可近性指標、技術採納、法規環境、消費行為和醫療服務模式。研究檢驗屈光不正、屈光、白內障、青光眼、糖尿病視網膜病變、老齡化黃斑部病變、乾眼症、兒童近視、隱形眼鏡安全性和數位眼疲勞。透過醫療基礎設施、醫護人員配備、都市區醫療服務可近性、疾病流行模式、篩檢工作以及數位化準備情況，評估區域和國家層面的具體情況。人工智慧和數位醫療方面的洞察則基於檢驗狀態、預期用途、監管核准情況、互通性、隱私保護以及對臨床工作流程的影響進行評估。本調查方法避免了不實假設，並排除了基於市場規模、市場佔有率和預測的論斷，而是專注於已驗證的趨勢和戰略信息，以輔助檢驗。

結論：推廣可及的、實證的視力保健服務。

眼科正逐漸成為預防醫學、提高生產力、促進教育、實現健康老化和提升數位福祉的核心要素。最大的機會在於改善精準屈光病人歷程的可近性、有效管理兒童近視、支持老齡化性眼科疾病診療、擴大糖尿病視網膜病變篩檢，以及利用數位化工具建構更完善的患者就診流程。人工智慧、遠距眼科、先進鏡片和數據驅動的醫療協調可以提高效率和涵蓋範圍，但其影響取決於臨床檢驗、負責任的管治以及與訓練有素的專業人員的合作。區域差異依然顯著。成熟的醫療體系專注於品質、老化和數位整合，而新興和醫療服務不足的地區則需要價格合理的視力矯正、社區篩檢、人才培養和可擴展的服務模式。能夠將創新與實證醫學、可負擔性、合規性和患者信任相結合的行業領導者，將最有能力改善眼部健康狀況。未來視力保健的發展將不再由孤立的產品主導，而是由一個整合了預防、診斷、矯正、治療、後續觀察和教育等服務，並涵蓋不同人群的綜合生態系統塑造。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 視力保健市場：依產品分類

  • 隱形眼鏡
    • 硬式高透氧
    • 柔軟的
      • 日用一次性用品
      • 長期穿著
      • 一個月用完
  • 人工水晶體
  • 眼鏡鏡片

第8章：視力保健市場：依通路分類

  • 電子商務
  • 醫院和診所
  • 眼鏡零售商
  • 藥局

第9章 視力保健市場：依材料分類

  • 水凝膠
  • 聚甲基丙烯酸甲酯
  • 矽水凝膠

第10章：視力保健市場：依應用領域分類

  • 化妝品
    • 顯色效果
    • 時尚鏡頭
  • 醫學領域
    • 散光矯正
    • 白內障手術
    • 抑制近視進展
    • 老花眼矯正

第11章 視力保健市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章 視力保健市場：按群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 視力保健市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Alcon AG
  • Bausch & Lomb Corporation
  • Carl Zeiss AG
  • Corza Medical, Inc.
  • EssilorLuxottica SA
  • Fielmann Group AG
  • Glaukos Corporation
  • Haag-Streit Holding AG
  • Heidelberg Engineering GmbH
  • HOYA Corporation
  • Johnson & Johnson
  • Lumenis Be Ltd.
  • Marcolin SpA
  • Menicon Co., Ltd.
  • NIDEK Co., Ltd.
  • Nikon Corporation
  • OCULUS Optikgerate GmbH
  • Optovue, Inc.
  • Quantel Medical SA
  • Rodenstock GmbH
  • Safilo Group SpA
  • Seiko Optical Products Co., Ltd.
  • Shamir Optical Industry Ltd.
  • STAAR Surgical Company
  • The Cooper Companies, Inc.
  • Tokai Optical Co., Ltd.
  • Topcon Corporation
  • Younger Mfg. Co.
  • Ziemer Ophthalmic Systems AG
Product Code: MRR-742BD5185120

The Vision Care Market is projected to grow by USD 162.51 billion at a CAGR of 8.50% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 91.78 billion
Estimated Year [2026] USD 98.58 billion
Forecast Year [2032] USD 162.51 billion
CAGR (%) 8.50%

Vision Care Executive Summary: Eye Health, Access, and Digital Transformation

Vision care is evolving from a product-centered category into a broader eye health ecosystem spanning prescription eyewear, contact lenses, ophthalmic diagnostics, refractive correction, dry eye management, myopia control, digital eye strain solutions, and accessible primary eye care. Demand is being shaped by aging populations, rising screen exposure, growing awareness of preventable vision impairment, and expanding access to optometry and ophthalmology services. According to the World Health Organization, at least 2.2 billion people have near or distance vision impairment, and at least 1 billion cases could have been prevented or have yet to be addressed, underscoring the public health importance of timely eye care. Evidence consistently links uncorrected refractive error, cataract, glaucoma, diabetic retinopathy, and age-related macular degeneration with reduced productivity, impaired learning, avoidable disability, and higher care burdens. As a result, vision care is increasingly positioned as an essential health service rather than a discretionary consumer purchase. The sector is also being influenced by lifestyle shifts, including hybrid work, extended digital device use, outdoor activity deficits among children, and higher prevalence of metabolic diseases that affect ocular health. These forces are encouraging stakeholders to combine clinical quality, affordability, early detection, patient education, and omnichannel delivery. For industry leaders, the central opportunity lies in improving access to accurate eye examinations, evidence-based treatment pathways, durable corrective products, and digitally enabled continuity of care while navigating regulation, reimbursement variability, workforce constraints, and consumer expectations for convenience and personalization.

Transformative Shifts Reshaping Vision Care Delivery

The vision care landscape is undergoing transformative shifts driven by preventive eye health, connected diagnostics, and patient-centric service models. Consumers are increasingly seeking convenience through online appointment booking, digital prescription management, home delivery of eyewear and contact lenses, and seamless movement between physical clinics and digital channels. At the same time, clinical standards remain central because accurate refraction, ocular disease screening, contact lens fitting, and surgical referral require trained professionals and validated devices. Myopia management has become a major strategic priority, particularly as childhood myopia rises in many urbanized regions and evidence supports interventions such as increased outdoor time, specialized optical designs, atropine protocols, and structured monitoring. Dry eye disease and digital eye strain are also reshaping demand as prolonged screen use contributes to discomfort, reduced visual performance, and greater use of lubricants, ergonomic education, and clinical evaluation. Another important shift is the integration of eye care with chronic disease management, especially diabetes and hypertension, where retinal assessment supports earlier detection of complications. The International Diabetes Federation estimates that hundreds of millions of adults live with diabetes globally, reinforcing the need for systematic diabetic retinopathy screening and referral pathways. Regulatory scrutiny is increasing around medical devices, online vision testing, contact lens safety, data privacy, and advertising claims, making compliance and clinical governance vital differentiators. Sustainability is also becoming more relevant as providers and manufacturers address packaging waste, lens disposal, frame materials, energy use, and responsible supply chains.

Cumulative Impact of Artificial Intelligence in Vision Care

Artificial intelligence is creating a cumulative impact across vision care by improving screening efficiency, clinical workflow, patient triage, and operational decision-making. AI-enabled image analysis is particularly relevant in retinal screening for diabetic retinopathy, glaucoma risk indicators, age-related macular degeneration features, and other ocular findings, where validated systems can support earlier referral and reduce bottlenecks in settings with limited specialist capacity. In optometry and ophthalmology practices, AI can assist with appointment prioritization, diagnostic documentation, visual field interpretation support, lens recommendation workflows, and patient communication. AI-powered personalization is also strengthening the consumer experience by supporting frame selection, virtual try-on, reminder systems, adherence prompts for contact lens replacement, and education tailored to patient risk profiles. However, adoption must be grounded in evidence, transparency, regulatory compliance, and responsible data governance. Clinical AI requires representative datasets, ongoing validation, clear accountability, interoperability with existing systems, and safeguards against bias that could affect underserved populations. The greatest impact will come when artificial intelligence complements, rather than replaces, qualified eye care professionals by automating repetitive tasks, expanding screening reach, and enabling more consistent follow-up. Organizations that combine AI with human oversight, secure health data infrastructure, and measurable clinical outcomes are better positioned to improve access and quality across the vision care continuum.

Key Regional Insights Across Asia-Pacific, North America, Latin America, Europe, the Middle East, and Africa

Asia-Pacific is a critical region for vision care because of its large population base, rapid urbanization, high burden of refractive error, and strong need for scalable myopia management and cataract services. The region includes several countries reporting high rates of school-age myopia, and public health programs increasingly emphasize school vision screening, outdoor activity promotion, optical retail access, and digital health adoption, while disparities remain between metropolitan and rural eye care availability. North America demonstrates mature demand for prescription eyewear, contact lenses, ophthalmic diagnostics, refractive surgery, dry eye care, and chronic eye disease monitoring, supported by advanced clinical infrastructure, consumer awareness, and high digital engagement, though affordability and rural specialist access remain persistent concerns. Latin America is shaped by a combination of urban optical retail development, public health needs related to preventable vision impairment, and uneven access to specialist services across income groups and geographies, making affordable refraction and cataract pathways essential. Europe benefits from established healthcare systems, strong regulatory frameworks for medical devices, aging demographics, and demand for quality eye examinations, presbyopia solutions, cataract care, glaucoma follow-up, and retinal disease management. The Middle East is advancing through investments in specialty healthcare, diabetes-related eye screening, premium optical services, and growing medical tourism in selected markets, though access gaps persist in lower-resource areas and among remote populations. Africa presents substantial unmet need in uncorrected refractive error, cataract services, and preventable blindness, with opportunities linked to community screening, affordable spectacles, workforce development, mobile eye care, and partnerships that expand primary eye health access.

Key Group Insights Covering ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN vision care dynamics are shaped by young populations, urban screen exposure, rising childhood myopia, and expanding optical retail networks, creating strong relevance for school-based screening, affordable corrective lenses, and digital patient engagement across diverse income settings. GCC countries are influenced by high healthcare investment, elevated diabetes prevalence, demand for premium eye care services, and increasing use of advanced ophthalmic diagnostics, making integrated retinal screening and specialty care pathways particularly important. The European Union emphasizes regulated medical devices, patient safety, cross-border standards, sustainability, and access through mixed public and private care models, supporting consistent quality requirements across eyewear, contact lenses, diagnostics, and surgical pathways. BRICS markets combine large populations, diverse income levels, manufacturing capacity, and high unmet need, making scalable affordability, local distribution, teleophthalmology, and public-private screening models essential to improving vision care access. G7 countries generally have advanced clinical infrastructure, aging populations, high rates of presbyopia and chronic ocular disease, and significant digital health readiness, which supports innovation in diagnostics, AI-enabled screening, and personalized vision correction. NATO member countries overlap with several developed and emerging healthcare systems where defense, occupational readiness, workforce productivity, and access to corrective vision services are important, particularly for safety-sensitive roles that require accurate visual performance and regular eye health monitoring.

Key Country Insights for Major Vision Care Markets

The United States remains a highly developed vision care environment with strong demand for eye examinations, eyewear, contact lenses, dry eye treatment, refractive procedures, and retinal disease monitoring, while affordability, insurance coverage, and rural access remain important concerns. Canada combines aging demographics, public health awareness, and regional differences in coverage for optometry and ophthalmology services, making access and continuity of care key priorities. Mexico is seeing growing demand for optical products and eye health services in urban centers, alongside continued need for affordable refractive correction and cataract access. Brazil has a large need for corrective vision, diabetic eye screening, and cataract care, supported by urban healthcare capacity but challenged by geographic and income disparities. The United Kingdom has well-established optometry access, structured eye examination pathways, and rising pressure from aging-related eye disease and ophthalmology waiting times. Germany is characterized by high-quality clinical standards, demand for premium lenses and ophthalmic technology, and strong relevance for presbyopia, cataract, and retinal care. France combines regulated healthcare access, mature optical demand, and continued focus on reimbursement, quality, and timely specialist referral. Russia presents broad demand for refractive correction and ophthalmology services across a large geography, with access differences between major cities and remote regions. Italy and Spain both reflect aging populations, demand for presbyopia and cataract solutions, and growing attention to retinal disease, dry eye, and digital eye strain. China faces a significant myopia burden, especially among children and students, along with rising demand for ophthalmic diagnostics, myopia control, cataract services, and digital health-enabled screening. India has substantial unmet need in refractive correction, cataract treatment, and diabetic retinopathy screening, making affordability, community outreach, teleophthalmology, and local service capacity central to progress. Japan combines one of the world's oldest populations with high myopia prevalence and advanced demand for cataract, glaucoma, retinal disease, and premium optical solutions. Australia benefits from strong optometry access and public health awareness, while remote and Indigenous communities require targeted outreach and culturally appropriate services. South Korea is marked by high digital device use, significant myopia prevalence, advanced ophthalmic capabilities, and consumer demand for premium eyewear, contact lenses, and refractive care.

Actionable Recommendations for Vision Care Industry Leaders

Industry leaders should prioritize clinically validated, accessible, and patient-centered vision care models. First, expand early detection by integrating comprehensive eye examinations, school vision screening, workplace eye health programs, and chronic disease-linked retinal assessment. Second, strengthen myopia management capabilities with evidence-based protocols, parent education, regular follow-up, and appropriate optical or pharmaceutical interventions aligned with local regulations. Third, improve affordability through tiered product portfolios, durable low-cost spectacles, inclusive financing, and partnerships with public health organizations in underserved areas. Fourth, invest in omnichannel service delivery that connects physical clinics, optical retail, teleophthalmology, secure records, and digital reminders without compromising clinical accuracy. Fifth, adopt AI and automation only where validation, privacy, bias mitigation, and professional oversight are clearly established. Sixth, address workforce constraints by supporting optometrist and technician training, referral coordination, and task-sharing models that preserve quality. Seventh, build trust through transparent claims, contact lens safety education, post-surgical follow-up, and clear communication on treatment limitations. Finally, embed sustainability into product design, packaging, logistics, and recycling initiatives, as environmentally responsible practices are increasingly relevant to procurement, regulation, and consumer choice.

Research Methodology for Evidence-Based Vision Care Intelligence

A robust vision care research methodology should combine primary and secondary evidence to ensure accuracy, relevance, and practical value. Primary research includes structured interviews with optometrists, ophthalmologists, optical retailers, lens specialists, diagnostic providers, public health experts, procurement professionals, and patient-facing service operators. Secondary research draws from peer-reviewed ophthalmology and optometry literature, World Health Organization resources, public health databases, regulatory publications, clinical guidelines, demographic datasets, reimbursement references, medical device standards, and national eye health programs. Evidence is triangulated across clinical burden, access indicators, technology adoption, regulatory context, consumer behavior, and care delivery models. Special attention is given to refractive error, presbyopia, cataract, glaucoma, diabetic retinopathy, age-related macular degeneration, dry eye disease, pediatric myopia, contact lens safety, and digital eye strain. Regional and country insights are assessed through healthcare infrastructure, workforce availability, urban-rural access, disease prevalence patterns, screening initiatives, and digital readiness. Artificial intelligence and digital health findings are evaluated based on validation status, intended use, regulatory acceptance, interoperability, privacy, and clinical workflow impact. The methodology avoids unsupported assumptions and excludes market sizing, market share, and forecast-based claims, focusing instead on verified trends and decision-useful strategic intelligence.

Conclusion: Advancing Accessible, Evidence-Based Vision Care

Vision care is becoming a core component of preventive healthcare, productivity, education, healthy aging, and digital wellbeing. The strongest opportunities are linked to improving access to accurate refraction, managing childhood myopia, supporting aging-related eye disease care, expanding diabetic retinal screening, and using digital tools to create more connected patient journeys. Artificial intelligence, teleophthalmology, advanced lenses, and data-enabled care coordination can improve efficiency and reach, but their impact depends on clinical validation, responsible governance, and integration with trained professionals. Regional differences remain significant: mature healthcare systems are focused on quality, aging populations, and digital integration, while emerging and underserved regions require affordable correction, community screening, workforce development, and scalable service models. Industry leaders that align innovation with evidence, affordability, compliance, and patient trust will be best positioned to strengthen eye health outcomes. The future of vision care will be defined not by isolated products, but by integrated ecosystems that combine prevention, diagnosis, correction, treatment, follow-up, and education across diverse populations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Vision Care Market, by Product

  • 7.1. Introduction
  • 7.2. Contact Lenses
    • 7.2.1. Rigid Gas Permeable
    • 7.2.2. Soft
      • 7.2.2.1. Daily Disposable
      • 7.2.2.2. Extended Wear
      • 7.2.2.3. Monthly Disposable
  • 7.3. Intraocular Lenses
  • 7.4. Spectacle Lenses

8. Vision Care Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. E-Commerce
  • 8.3. Hospital & Clinics
  • 8.4. Optical Retailers
  • 8.5. Pharmacies

9. Vision Care Market, by Material

  • 9.1. Introduction
  • 9.2. Hydrogel
  • 9.3. Polymethyl Methacrylate
  • 9.4. Silicone Hydrogel

10. Vision Care Market, by Application

  • 10.1. Introduction
  • 10.2. Cosmetic
    • 10.2.1. Color Enhancement
    • 10.2.2. Fashion Lens
  • 10.3. Medical
    • 10.3.1. Astigmatism Correction
    • 10.3.2. Cataract Surgery
    • 10.3.3. Myopia Control
    • 10.3.4. Presbyopia Correction

11. Vision Care Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Vision Care Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Vision Care Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. FPNV Positioning Matrix, 2025
  • 14.3. Market Concentration Analysis, 2025
    • 14.3.1. Concentration Ratio (CR)
    • 14.3.2. Herfindahl Hirschman Index (HHI)
  • 14.4. Recent Developments & Impact Analysis, 2025
  • 14.5. Product Portfolio Analysis, 2025
  • 14.6. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Alcon AG
  • 15.2. Bausch & Lomb Corporation
  • 15.3. Carl Zeiss AG
  • 15.4. Corza Medical, Inc.
  • 15.5. EssilorLuxottica SA
  • 15.6. Fielmann Group AG
  • 15.7. Glaukos Corporation
  • 15.8. Haag-Streit Holding AG
  • 15.9. Heidelberg Engineering GmbH
  • 15.10. HOYA Corporation
  • 15.11. Johnson & Johnson
  • 15.12. Lumenis Be Ltd.
  • 15.13. Marcolin S.p.A.
  • 15.14. Menicon Co., Ltd.
  • 15.15. NIDEK Co., Ltd.
  • 15.16. Nikon Corporation
  • 15.17. OCULUS Optikgerate GmbH
  • 15.18. Optovue, Inc.
  • 15.19. Quantel Medical SA
  • 15.20. Rodenstock GmbH
  • 15.21. Safilo Group S.p.A.
  • 15.22. Seiko Optical Products Co., Ltd.
  • 15.23. Shamir Optical Industry Ltd.
  • 15.24. STAAR Surgical Company
  • 15.25. The Cooper Companies, Inc.
  • 15.26. Tokai Optical Co., Ltd.
  • 15.27. Topcon Corporation
  • 15.28. Younger Mfg. Co.
  • 15.29. Ziemer Ophthalmic Systems AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL VISION CARE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VISION CARE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VISION CARE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VISION CARE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VISION CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VISION CARE MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL VISION CARE MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VISION CARE MARKET SIZE, BY MATERIAL, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VISION CARE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VISION CARE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VISION CARE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VISION CARE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VISION CARE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VISION CARE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VISION CARE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VISION CARE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VISION CARE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VISION CARE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 21. GLOBAL VISION CARE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL VISION CARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL VISION CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONTACT LENSES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONTACT LENSES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONTACT LENSES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RIGID GAS PERMEABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RIGID GAS PERMEABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RIGID GAS PERMEABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SOFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SOFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SOFT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DAILY DISPOSABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DAILY DISPOSABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DAILY DISPOSABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL EXTENDED WEAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL EXTENDED WEAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL EXTENDED WEAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MONTHLY DISPOSABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MONTHLY DISPOSABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MONTHLY DISPOSABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTRAOCULAR LENSES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAOCULAR LENSES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTRAOCULAR LENSES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SPECTACLE LENSES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SPECTACLE LENSES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SPECTACLE LENSES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL E-COMMERCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL E-COMMERCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL E-COMMERCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HOSPITAL & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HOSPITAL & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HOSPITAL & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL OPTICAL RETAILERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL OPTICAL RETAILERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL OPTICAL RETAILERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HYDROGEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HYDROGEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HYDROGEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL POLYMETHYL METHACRYLATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL POLYMETHYL METHACRYLATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL POLYMETHYL METHACRYLATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SILICONE HYDROGEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SILICONE HYDROGEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SILICONE HYDROGEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL COSMETIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL COSMETIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL COSMETIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL COLOR ENHANCEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL COLOR ENHANCEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL COLOR ENHANCEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FASHION LENS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FASHION LENS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FASHION LENS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ASTIGMATISM CORRECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ASTIGMATISM CORRECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ASTIGMATISM CORRECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CATARACT SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CATARACT SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CATARACT SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MYOPIA CONTROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MYOPIA CONTROL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MYOPIA CONTROL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PRESBYOPIA CORRECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PRESBYOPIA CORRECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PRESBYOPIA CORRECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL VISION CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC VISION CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA VISION CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA VISION CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE VISION CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST VISION CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA VISION CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL VISION CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN VISION CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 141. GCC VISION CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GCC VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 143. GCC VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 144. GCC VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 145. GCC VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. GCC VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 147. GCC VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. GCC VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 149. GCC VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION VISION CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS VISION CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 168. G7 VISION CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. G7 VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 170. G7 VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 171. G7 VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 172. G7 VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. G7 VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 174. G7 VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. G7 VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 176. G7 VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 177. NATO VISION CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 178. NATO VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 179. NATO VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 180. NATO VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 181. NATO VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. NATO VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 183. NATO VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. NATO VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 185. NATO VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL VISION CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES VISION CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 196. CANADA VISION CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. CANADA VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 198. CANADA VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 199. CANADA VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 200. CANADA VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. CANADA VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 202. CANADA VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. CANADA VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 204. CANADA VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 205. MEXICO VISION CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. MEXICO VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 207. MEXICO VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 208. MEXICO VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 209. MEXICO VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. MEXICO VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 211. MEXICO VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. MEXICO VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 213. MEXICO VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 214. BRAZIL VISION CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. BRAZIL VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 216. BRAZIL VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 217. BRAZIL VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 218. BRAZIL VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. BRAZIL VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 220. BRAZIL VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. BRAZIL VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 222. BRAZIL VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED KINGDOM VISION CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED KINGDOM VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED KINGDOM VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED KINGDOM VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED KINGDOM VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED KINGDOM VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED KINGDOM VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED KINGDOM VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED KINGDOM VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 232. GERMANY VISION CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. GERMANY VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 234. GERMANY VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 235. GERMANY VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 236. GERMANY VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. GERMANY VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 238. GERMANY VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. GERMANY VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 240. GERMANY VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 241. FRANCE VISION CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. FRANCE VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 243. FRANCE VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 244. FRANCE VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 245. FRANCE VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. FRANCE VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 247. FRANCE VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. FRANCE VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 249. FRANCE VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 250. RUSSIA VISION CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. RUSSIA VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 252. RUSSIA VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 253. RUSSIA VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 254. RUSSIA VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 255. RUSSIA VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 256. RUSSIA VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. RUSSIA VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 258. RUSSIA VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 259. ITALY VISION CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. ITALY VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 261. ITALY VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 262. ITALY VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 263. ITALY VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 264. ITALY VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 265. ITALY VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. ITALY VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 267. ITALY VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 268. SPAIN VISION CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. SPAIN VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 270. SPAIN VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 271. SPAIN VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 272. SPAIN VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 273. SPAIN VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 274. SPAIN VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. SPAIN VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 276. SPAIN VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA VISION CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 286. INDIA VISION CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. INDIA VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 288. INDIA VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 289. INDIA VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 290. INDIA VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 291. INDIA VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 292. INDIA VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 293. INDIA VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 294. INDIA VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 295. JAPAN VISION CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 296. JAPAN VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 297. JAPAN VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 298. JAPAN VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 299. JAPAN VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 300. JAPAN VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 301. JAPAN VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 302. JAPAN VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 303. JAPAN VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 304. AUSTRALIA VISION CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 305. AUSTRALIA VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 306. AUSTRALIA VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 307. AUSTRALIA VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 308. AUSTRALIA VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 309. AUSTRALIA VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 310. AUSTRALIA VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 311. AUSTRALIA VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 312. AUSTRALIA VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 313. SOUTH KOREA VISION CARE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. SOUTH KOREA VISION CARE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 315. SOUTH KOREA VISION CARE MARKET SIZE, BY CONTACT LENSES, 2018-2032 (USD MILLION)
  • TABLE 316. SOUTH KOREA VISION CARE MARKET SIZE, BY SOFT, 2018-2032 (USD MILLION)
  • TABLE 317. SOUTH KOREA VISION CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 318. SOUTH KOREA VISION CARE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 319. SOUTH KOREA VISION CARE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 320. SOUTH KOREA VISION CARE MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 321. SOUTH KOREA VISION CARE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 322. GLOBAL VISION CARE MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 323. GLOBAL VISION CARE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025